Daiichi Sankyō

Daiichi Sankyo is a global pharmaceutical corporation founded in Japan. The company offers unique goods and services in over 20 countries worldwide. With over 100 years of scientific experience, the company depends on a rich tradition of invention as well as a healthy pipeline of promising new medications to assist patients.

They generate revolutionary new and generic medicines, as well as new ways of drug research and delivery, thanks to the great knowledge and commitment of 15,000 employees globally. They share a passion for innovation as well as compassion for the patients who require our medicines all around the world.

In accordance with their purpose, they have selected "Core Values and Core Behaviors" as the foundation for a cooperative attitude and accurate value judgments, as well as the criterion for our company activities and decision-making. Furthermore, they have formed the Daiichi Sankyo Group Corporate Conduct Charter in order to conduct with the highest ethical standards and a social conscience befitting a company involved in a business that touches human lives.

Founded: Tokyo, Japan (2005) (by merger)

Headquarters: Daiichi Sankyo Building A/B 3-5-1, Nihonbashi-honcho, Chūō-ku, Tokyo 103-8426, Japan

Key people: Sunao Manabe (Representative Director and President), Ken Keller (President and CEO, Daiichi Sankyo, Inc.)

Website: https://www.daiichisankyo.com/